Publications by authors named "James D Buschbach"

Claim this Profile
S
Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma.
Emily E Seiden, Spencer M Richardson, Leah A Everitt, Gabrielle J Knafler, Alyssa L Walker, James D Buschbach

Cancer Res Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids.
Emily E Seiden, Spencer M Richardson, Leah A Everitt, Gabrielle J Knafler, Gavin P Kinsella, James D Buschbach

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for Clemons et al., "Cytosolic Delivery of Multidomain Cargos by the N Terminus of Pasteurella multocida Toxin".
Nathan C Clemons, Yuka Bannai, Elizabeth E Haywood, Yiting Xu, James D Buschbach

Infect Immun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytosolic Delivery of Multidomain Cargos by the N Terminus of Pasteurella multocida Toxin.
Nathan C Clemons, Yuka Bannai, Elizabeth E Haywood, Yiting Xu, James D Buschbach

Infect Immun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis